Huaxiang L. Wang
Shiyan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
In-depth summary of adverse events associated with Flurbiprofen: A real-world pharmacovigilance study from 2004 to 2024 using the FAERS database.
Journal: PloS one
Published: April 03, 2025
Unveiling the nexus of p53 and PD-L1: insights into immunotherapy resistance mechanisms in hepatocellular carcinoma.
Journal: American journal of cancer research
Published: January 26, 2025
Post marketing safety surveillance of atezolizumab based on a retrospective analysis of the FDA adverse events reporting system (FAERS).
Journal: Scientific reports
Published: January 16, 2025
A real-world drug safety surveillance study from the FAERS database of hepatocellular carcinoma patients receiving pembrolizumab alone and plus lenvatinib.
Journal: Scientific reports
Published: November 14, 2024
Analysis of spontaneous nystagmus and the frequency characteristics of affected semicircular canals in patients with vestibular neuritis
Journal: Zhonghua nei ke za zhi
Published: July 03, 2023
SNRPD1 inhibition suppresses the proliferation of hepatocellular carcinoma and promotes autophagy through the PI3K/AKT/mTOR/4EBP1 pathway.
Journal: Archives of biochemistry and biophysics
Published: March 30, 2023
Upregulation of HCFC1 expression promoted hepatocellular carcinoma progression through inhibiting cell cycle arrest and correlated with immune infiltration.
Journal: Journal of Cancer
Published: March 23, 2023
Pre- to postoperative alpha-fetoprotein ratio-based nomogram to predict tumor recurrence in patients with hepatocellular carcinoma.
Journal: Frontiers in oncology
Published: December 31, 2022
Nomogram Based on Platelet-Albumin-Bilirubin for Predicting Tumor Recurrence After Surgery in Alpha-Fetoprotein-Negative Hepatocellular Carcinoma Patients.
Journal: Journal of hepatocellular carcinoma
Published: November 06, 2022
Last Updated: 09/26/2026